Search results
The Zacks Analyst Blog Highlights Merck, Vertex Pharmaceuticals, Immunocore Holdings and Immunovant
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 19, 2022 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights J&J, Novartis, GSK, Merck and AbbVie
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 25, 2022 – Zacks.com announces the list of stocks featured...
Can You Still Buy the Dow Jones' Best-Performing April Stocks?
Motley Fool· 1 year agoLet's face it -- we'd all rather buy stocks when they're down rather than up. Some investors...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
These 10 Non-Covid Biotech Stocks Are Up 40% Or More This Year
Investor's Business Daily· 2 years agoBiotech stocks are scorching hot right now as Big Pharma stalwarts like Pfizer and Bristol Myers...
Here's How Much a $1000 Investment in Ligand Pharmaceuticals Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo Finance· 1 year agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Got $1,000 to Invest in Stocks? Put It in This Index Fund
Motley Fool via Yahoo Finance· 3 months agoDeciding how to invest your hard-earned money can feel like being a kid at a candy store. There are...
Why OPKO Health Shares Jumped on Wednesday
Motley Fool· 1 year agoShares of drug and diagnostics company OPKO Health (NASDAQ: OPK) closed 8% higher Wednesday following news of a collaboration agreement with...
7 Healthcare Stocks That Will Be Big Winners in 2023
InvestorPlace via Yahoo Finance· 1 year agoHealthcare stocks performed well in 2022, driven by a number of factors. One of the main drivers was the ongoing COVID-19 pandemic, which continued to...
2 “Strong Buy” Penny Stocks With Over 200% Upside on the Horizon
TipRanks via Yahoo Finance· 1 year agoPenny stocks are controversial, to say the least. When it comes to these under $5 per share...
